Third Molar Extraction Completed Phase 3 Trials for Dexmedetomidine (DB00633)

IndicationStatusPhase
DBCOND0035848 (Third Molar Extraction)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00971178Analgesic Effect of Peripheral DexmedetomidineTreatment